Cargando…
Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory
Coronavirus disease 2019 (COVID-19) is associated with extreme inflammatory response, disordered hemostasis and high thrombotic risk. A high incidence of thromboembolic events has been reported despite thromboprophylaxis, raising the question of a more effective anticoagulation. First-line hemostasi...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474970/ https://www.ncbi.nlm.nih.gov/pubmed/32922211 http://dx.doi.org/10.1186/s12959-020-00230-1 |